ISGD Welcomes 4 New Board Appointments

Published on August 21, 2026
ISGD Welcomes 4 New Board Appointments
Continue reading on website
Other news

Cardiometabolic Risk, Evaluation, and Control in Lupus Nephritis

August 7, 2026
AbstractIntroduction: Lupus nephritis (LN) is associated with atherosclerotic cardiovascular disease but early recognition of cardiometabolic risk in patients with LN can facilitate risk optimization with disease-modifying strategies. To identify potential gaps in cardiometabolic risk management in LN in real-world practice, we aimed to evaluate the prevalence and trend in cardiometabolic risk, ev

Quantitative Proteomics: Recent Advances in Glomerular Disease and Nephrotic Syndrome

October 1, 2026
AbstractBackground: Chronic kidney disease (CKD) affects nearly 10% (∼850 million people) of the global population and stands among leading causes of morbidity, mortality, and healthcare cost. Current clinical biomarkers including serum creatinine, estimated glomerular filtration rate (eGFR), and proteinuria, are all lagging indicators of nephron damage only after glomerular and podocyte injury an